Document is current
Any future updates will be listed below
-
Authors
Voter, Andrew F.
Amindarolzarbi, Alireza
Shen, Colette J.
Wang, Jarey
Kang, Hyunseok
Sharma, Rajni
Solnes, Lilja B.
Pomper, Martin G.
Bishop, Justin A.
Rowe, Steven P.
Kiess, Ana P.
-
Funding
Funding for this research was provided by:
National Institutes of Health
Walter and Mary Ciceric Research Award
Mecheri Mosur Family Research Fund
Adenoid Cystic Carcinoma Research Foundation
- License Information
-
More Information
Article History
Received: 15 March 2025
Accepted: 6 May 2025
First Online: 16 May 2025
Declarations
:
: C.J.S reports personal fees from Nanobiotix, Johnson & Johnson, and GT Medical Technologies and grants from AstraZeneca, outside the submitted work. M.G.P. has a patent (US 9,861,713 B2) with royalties paid to Lantheus Holdings. Under a license agreement between Progenics and the Johns Hopkins University, M.J.P. and the University are entitled to royalties on an invention described in this article. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. S.P.R. has a consulting agreement with Lantheus. A.P.K. reports clinical trial funding from Novartis, Bayer, Merck, and Lantheus, outside the submitted work. A.F.V., A.A., J.W., H.K., R.S., L.B.S., J.A.B. have no relevant conflicts to report.
